Interestingly, CASP9 has already been known as a multimodal therapeutic target with diverse cellular expression in human disease, and CASP9 polymorphisms have been linked with various cancers, neurological disorders, autoimmune pathologies, and lumbar disc disease (Avrutsky and Troy, 2021). This evidence concerns the gene CASP9 and cancer.